Search research articles
Contact Us
Filters
Showing results (21-30 of 156) with videos related to
Page
of 16
Sort By:
Biochemical and Biophysical Research Communications
|
September 7, 2011
Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide
Zhengming Chen, Jun Zhou, Yingtao Zhang, et al.
The International Journal of Biochemistry & Cell Biology
|
June 30, 2007
Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality
George R Simon, Roohi Ismail-Khan, Gerold Bepler
Plos One
|
March 12, 2014
Ubiquitination and degradation of ribonucleotide reductase M1 by the polycomb group proteins RNF2 and Bmi1 and cellular response to gemcitabine
Yingtao Zhang, Xin Li, Zhengming Chen, et al.
Fetal and Pediatric Pathology
|
November 4, 2010
Thymidylate synthase 1 (TS1) in-situ protein expression predicts the survival of Ewing/PNET
Marilyn M Bui, Zhong Zheng, Scott Antonia, et al.
Chest
|
July 9, 2005
Small tumor size and limited smoking history predicts activated epidermal growth factor receptor in early-stage non-small cell lung cancer
Zhong Zheng, Gerold Bepler, Alan Cantor, et al.
Journal of Cancer Biology
|
November 8, 2021
Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine
Xiaohong Mary Zhang, Navnath Gavande, Prahlad Parajuli, et al.
Journal of Nucleic Acids
|
October 27, 2010
Modulation of the ribonucleotide reductase-antimetabolite drug interaction in cancer cell lines
Jun Zhou, Paula Oliveira, Xueli Li, et al.
Clinical Lung Cancer
|
May 5, 2010
Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer
Sang-Haak Lee, Tingan Chen, Jun Zhou, et al.
Antioxidants (Basel, Switzerland)
|
October 27, 2022
The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19
Ananda S Prasad, Agnes Malysa, Gerold Bepler, et al.
Oncology (Williston Park, N.Y.)
|
October 21, 2009
Neoadjuvant chemotherapy for resectable non-small-cell lung cancer
Jhanelle Gray, Eric Sommers, Miguel Alvelo-Rivera, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 156) with videos related to
Sort By:
Page
of 16
Biochemical and Biophysical Research Communications
|
September 7, 2011
Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide
Zhengming Chen, Jun Zhou, Yingtao Zhang, et al.
The International Journal of Biochemistry & Cell Biology
|
June 30, 2007
Nuclear excision repair-based personalized therapy for non-small cell lung cancer: from hypothesis to reality
George R Simon, Roohi Ismail-Khan, Gerold Bepler
Plos One
|
March 12, 2014
Ubiquitination and degradation of ribonucleotide reductase M1 by the polycomb group proteins RNF2 and Bmi1 and cellular response to gemcitabine
Yingtao Zhang, Xin Li, Zhengming Chen, et al.
Fetal and Pediatric Pathology
|
November 4, 2010
Thymidylate synthase 1 (TS1) in-situ protein expression predicts the survival of Ewing/PNET
Marilyn M Bui, Zhong Zheng, Scott Antonia, et al.
Chest
|
July 9, 2005
Small tumor size and limited smoking history predicts activated epidermal growth factor receptor in early-stage non-small cell lung cancer
Zhong Zheng, Gerold Bepler, Alan Cantor, et al.
Journal of Cancer Biology
|
November 8, 2021
Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine
Xiaohong Mary Zhang, Navnath Gavande, Prahlad Parajuli, et al.
Journal of Nucleic Acids
|
October 27, 2010
Modulation of the ribonucleotide reductase-antimetabolite drug interaction in cancer cell lines
Jun Zhou, Paula Oliveira, Xueli Li, et al.
Clinical Lung Cancer
|
May 5, 2010
Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer
Sang-Haak Lee, Tingan Chen, Jun Zhou, et al.
Antioxidants (Basel, Switzerland)
|
October 27, 2022
The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19
Ananda S Prasad, Agnes Malysa, Gerold Bepler, et al.
Oncology (Williston Park, N.Y.)
|
October 21, 2009
Neoadjuvant chemotherapy for resectable non-small-cell lung cancer
Jhanelle Gray, Eric Sommers, Miguel Alvelo-Rivera, et al.
Page
of 16